Association between p53 codon 72 genetic polymorphism and tobacco use and lung cancer risk

Lung

Volumn 187, Issue 2, 2009, Pages 110-115

  Cáceres, Dante D ^a   Quiñones, Luis A ^b   Schroeder, Jane C ^c   Gil, Leonel D ^b   Irarrázabal, Carlos E ^d  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSITY OF CHILE   (Chile)

^c IL   (United States)

^d UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

Case control; Case only; Gene environment interaction; Genetic polymorphisms; Lung cancer; Risk effect modification; Synergistic effect

Indexed keywords

PROLINE; PROTEIN P53;

ADULT; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; CASE-CONTROL STUDIES; CHILE; CODON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67649126249     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-008-9133-3     Document Type: Article

References (42)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer Incidence in five continents, vol VII, No 143. Lyon, France: IARC Scientific Publications
2. Boffeta P, Trichopoulos D (2002) Prostate cancer. In: Adami HO, Hunter D, Trichopoulos D (eds) Textbook of cancer epidemiology. Oxford University Press, New York, pp 400-428
3. Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123(1 Suppl):21S-49S (Pubitemid 36135701)
4. Shields PG (2002) Molecular epidemiology of smoking and lung cancer. Oncogene 21(45):6870-6876 (Pubitemid 35221933)
5. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253(5015):49-53 (Pubitemid 21917115)
6. Levine AJ (1997) p53, the cellular gatekeeper for growth and division. Cell 88(3):323-331 (Pubitemid 27131374)
7. RA Weinberg 1991 Tumor suppressor genes Science 254 5035 1138 1146 (Pubitemid 21917438)
8. WP Bennett SP Hussain KH Vahakangas MA Khan PG Shields CC Harris 1999 Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer J Pathol 187 1 8 18 (Pubitemid 29009831)
9. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19(2):1092-1100 (Pubitemid 29046852)
10. YC Wang CY Chen SK Chen YY Chang P Lin 1999 p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis Clin Cancer Res 5 1 129 134 (Pubitemid 29045185)
11. X Jin X Wu JA Roth CI Amos TM King C Branch SE Honn MR Spitz 1995 Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotype Carcinogenesis 16 9 2205 2208
12. J To-Figueras M Gene J Gomez-Catalan C Galan J Firvida M Fuentes M Rodamilans E Huguet J Estape J Corbella 1996 Glutathione-S-transferase M1 and codon 72 p53 polymorphisms in a northwestern Mediterranean population and their relation to lung cancer susceptibility Cancer Epidemiol Biomarkers Prev 5 5 337 342 (Pubitemid 26139115)
13. M Tagawa M Murata H Kimura 1998 Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small-cell lung carcinoma: association with clinicopathological features Cancer Lett 128 1 93 99 (Pubitemid 28279370)
14. R Birgander A Sjalander A Rannug AK Alexandrie MI Sundberg J Seidegard G Tornling G Beckman L Beckman 1995 P53 polymorphisms and haplotypes in lung cancer Carcinogenesis 16 9 2233 2236
15. A Weston HM Ling-Cawley NE Caporaso ED Bowman RN Hoover BF Trump CC Harris 1994 Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer Carcinogenesis 15 4 583 587 (Pubitemid 24124397)
16. K Kawajiri K Nakachi K Imai J Watanabe S Hayashi 1993 Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer Carcinogenesis 14 6 1085 1089 (Pubitemid 23193532)
17. E Biros I Kalina I Biros A Kohut E Bogyiova J Salagovic J Stubna 2001 Polymorphism of the p53 gene within the codon 72 in lung cancer patients Neoplasma 48 5 407 411 (Pubitemid 33144720)
18. H Xiao SV Singh 2007 p53 regulates cellular responses to environmental carcinogen benzo[a]pyrene-7,8-diol-9,10-epoxide in human lung cancer cells Cell Cycle 6 14 1753 1761 (Pubitemid 47327929)
19. GP Pfeifer MF Denissenko M Olivier N Tretyakova SS Hecht P Hainaut 2002 Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers Oncogene 21 48 7435 7451 (Pubitemid 35305599)
20. GP Pfeifer P Hainaut 2003 On the origin of G → T transversions in lung cancer Mutat Res 526 1-2 39 43 (Pubitemid 36507210)
21. Shen YM, Troxel AB, Vedantam S, Penning TM, Field J. Comparison of p53 mutations induced by PAH o-quinones with those caused by anti-benzo[a]pyrene diol epoxide in vitro: role of reactive oxygen and biological selection. Chem Res Toxicol 19(11):1441-1450
22. CE Irarrazabal C Rojas R Aracena C Marquez L Gil 2003 Chilean pilot study on the risk of lung cancer associated with codon 72 polymorphism in the gene of protein p53 Toxicol Lett 144 1 69 76 (Pubitemid 36952611)
23. de la Calle-Martin O, Romero M, Fabregat V, Ercilla G, Vives J, Yague J (1990) MspI polymorphism of the human p53 gene. Nucleic Acids Res 18(16):4963 (Pubitemid 20280146)
24. Korf B (2000) Human genetics: a problem based approach, 2nd edn. Blackwell Science, Cambridge, MA
25. L Quiñones D Lucas J Godoy D Cáceres F Berthou N Varela K Lee C Acevedo L Martínez AM Aguilera L Gil 2001 CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms The effect of single and combined genotypes on lung cancer susceptibility in Chilean people Cancer Lett 174 1 35 44 (Pubitemid 33001306)
26. LD Botto MJ Khoury 2001 Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond Am J Epidemiol 153 10 1016 1020 (Pubitemid 32423788)
27. MJ Khoury WD Flanders 1996 Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls Am J Epidemiol 144 3 207 213 (Pubitemid 26313497)
28. DW Hosmer S Lemeshow 1992 Confidence interval estimation of interaction Epidemiology 3 5 452 456
29. C Poole 2001 Low P-values or narrow confidence intervals: which are more durable? Epidemiology 12 3 291 294 (Pubitemid 32336389)
30. STATA (2000) Intercooled STATA for Windows. 7th edn. STATA Corporation, College Station, TX
31. DP Miller G Liu I De Vivo TJ Lynch JC Wain L Su DC Christiani 2002 Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk Cancer Res 62 10 2819 2823 (Pubitemid 34525766)
32. R Fan MT Wu D Miller JC Wain KT Kelsey JK Wiencke DC Christiani 2000 The p53 codon 72 polymorphism and lung cancer risk Cancer Epidemiol Biomarkers Prev 9 10 1037 1042
33. A Weston LS Perrin K Forrester RN Hoover BF Trump CC Harris NE Caporaso 1992 Allelic frequency of a p53 polymorphism in human lung cancer Cancer Epidemiol Biomarkers Prev 1 6 481 483
34. G Liu DP Miller W Zhou SW Thurston R Fan LL Xu TJ Lynch JC Wain L Su DC Christiani 2001 Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma Cancer Res 61 24 8718 8722 (Pubitemid 34013882)
35. Szymanowska A, Jassem E, Dziadziuszko R, Borg A, Limon J, Kobierska-Gulida G, Rzyman W, Jassem J (2006) Increased risk of non-small cell lung cancer and frequency of somatic TP53 gene mutations in Pro72 carriers of TP53 Arg72Pro polymorphism. Lung Cancer 52(1):9-14 (Pubitemid 43340193)
36. Hu Y, McDermott MP, Ahrendt SA (2005) The p53 codon 72 proline allele is associated with p53 gene mutations in non-small cell lung cancer. Clin Cancer Res 11(7):2502-2509 (Pubitemid 40569446)
37. Popanda O, Edler L, Waas P, Schattenberg T, Butkiewicz D, Muley T, Dienemann H, Risch A, Bartsch H, Schmezer P (2007) Elevated risk of squamous-cell carcinoma of the lung in heavy smokers carrying the variant alleles of the TP53 Arg72Pro and p21 Ser31Arg polymorphisms. Lung Cancer 55(1):25-34 (Pubitemid 46038874)
38. Zhang X, Miao X, Guo Y, Tan W, Zhou Y, Sun T, Wang Y, Lin D (2006) Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer. Hum Mutat 27(1):110-117 (Pubitemid 43042973)
39. A Matakidou T Eisen RS Houlston 2003 TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis Mutagenesis 18 4 377 385 (Pubitemid 36850206)
40. Schabath MB, Wu X, Wei Q, Li G, Gu J, Spitz MR (2006) Combined effects of the p53 and p73 polymorphisms on lung cancer risk. Cancer Epidemiol Biomarkers Prev 15(1):158-161
41. Hong Y, Miao X, Zhang X, Ding F, Luo A, Guo Y, Tan W, Liu Z, Lin D (2005) The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 65(20):9582-9587 (Pubitemid 41508029)
42. Kuroda Y, Tsukino H, Nakao H, Imai H, Katoh T (2003) p53 Codon 72 polymorphism and urothelial cancer risk. Cancer Lett 189(1):77-83 (Pubitemid 35351522)